Meet Amprion’s Scientists/CoFounders, CEO Russ Lebovitz and CSO Claudio Soto, as they reminisce about Amprion’s scientific origin and the path they took the company to what it is today. Discover the link between Mad Cow disease and Alzheimer’s, Parkinson’s, as well as other neurodegenerative disorders. Early detection is the keystone in finding the cure. Amprion is revolutionizing EARLY DETECTION for Alzheimer’s and Parkinson’s by tracking the biomarkers or prions (aka misfolded proteins) in the brain prior to the start of any clinical symptoms, accelerating drug development along the process. Amprion’s mission is to empower people to navigate their brain health.